MET and neoplasm: The amplification of chromosomal regions containing the genes EGFR, MET, KIT, and PDGFRA is associated with the receptor tyrosine kinase (RTK) and growth-factor receptors, often driving proliferative and angiogenic signalling in tumours (8, 17).